These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826 [TBL] [Abstract][Full Text] [Related]
3. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095 [TBL] [Abstract][Full Text] [Related]
4. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer. Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386 [TBL] [Abstract][Full Text] [Related]
5. The diagnostic efficiency of seven autoantibodies in lung cancer. Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214 [TBL] [Abstract][Full Text] [Related]
6. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules. Huo Y; Guo Z; Gao X; Liu Z; Zhang R; Qin X J Cancer Res Clin Oncol; 2020 Dec; 146(12):3349-3357. PubMed ID: 32648227 [TBL] [Abstract][Full Text] [Related]
7. Clinical validation of an autoantibody test for lung cancer. Boyle P; Chapman CJ; Holdenrieder S; Murray A; Robertson C; Wood WC; Maddison P; Healey G; Fairley GH; Barnes AC; Robertson JF Ann Oncol; 2011 Feb; 22(2):383-9. PubMed ID: 20675559 [TBL] [Abstract][Full Text] [Related]
8. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules. Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380 [TBL] [Abstract][Full Text] [Related]
9. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200 [TBL] [Abstract][Full Text] [Related]
10. Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Jett JR; Peek LJ; Fredericks L; Jewell W; Pingleton WW; Robertson JF Lung Cancer; 2014 Jan; 83(1):51-5. PubMed ID: 24268382 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
12. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules. Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of a seven-autoantibody panel and a nomogram with a scoring table for predicting the risk of non-small-cell lung cancer. Wang W; Zhuang R; Ma H; Fang L; Wang Z; Lv W; Hu J Cancer Sci; 2020 May; 111(5):1699-1710. PubMed ID: 32108977 [TBL] [Abstract][Full Text] [Related]
14. Early detection of lung cancer by using an autoantibody panel in Chinese population. Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305 [TBL] [Abstract][Full Text] [Related]
15. Performance Evaluation of an Enzyme-Linked Immunosorbent Assay for Seven Autoantibodies in Lung Cancer. Yin-Yu M; Fu-Yi X; Fei-Bo W; Ri-Yi Z; Xiao-Lin Y Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969073 [TBL] [Abstract][Full Text] [Related]
17. Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer. Healey GF; Lam S; Boyle P; Hamilton-Fairley G; Peek LJ; Robertson JF J Thorac Dis; 2013 Oct; 5(5):618-25. PubMed ID: 24255775 [TBL] [Abstract][Full Text] [Related]
18. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer. Chen P; Lu W; Chen T J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232 [TBL] [Abstract][Full Text] [Related]
19. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432 [TBL] [Abstract][Full Text] [Related]
20. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer. Ma H; Wu T; Zhang Q; Ding Q BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]